Mirati Therapeutics
Why Robinhood?
You can watch MRTX and buy or sell other stocks, ETFs, and their options commission-free!About MRTX
Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer.
MRTX Key Statistics
Stock Snapshot
With a market cap of 4.12B, Mirati Therapeutics(MRTX) trades at $58.70. The stock has a price-to-earnings ratio of -4.80.
On 2026-03-02, Mirati Therapeutics(MRTX) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Mirati Therapeutics(MRTX) stock has reached 0, versus its average volume of 2.31M.
Over the past 52 weeks, Mirati Therapeutics(MRTX) stock has traded between a high of $64.41 and a low of $27.30.
Over the past 52 weeks, Mirati Therapeutics(MRTX) stock has traded between a high of $64.41 and a low of $27.30.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.